Paper
0
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Authors
Stefan Ciurea,Mei-Jie Zhang
Andrea Bacigalupo,Asad Bashey,Frederick Appelbaum,Omar Aljitawi,Philippe Armand,Joseph Antin,Junfang Chen,Steven Devine,Daniel Fowler,Leo Luznik,Ryotaro Nakamura,Paul O’Donnell,Miguel‐Angel Perales,Sai Pingali,David Porter,Marcie Riches,Olle Ringdén,Vanderson Rocha,Ravi Vij,Daniel Weisdorf,Richard Champlin,Mary Horowitz,Ephraim Fuchs,Mary Eapen
+24 authors
,O RingdénJournal
Published
Jul 1, 2015
Show more
Save
Tip0
TipSave
Abstract
Key Points Lower GVHD after haploidentical transplant with posttransplant cyclophosphamide compared with HLA-matched unrelated donor transplant. Comparable overall survival after haploidentical compared with matched unrelated donor transplant for AML.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.